Frozen Blood
Dept of Defense · DEFENSE HEALTH AGENCY (DHA)
This notice is not accepting responses (deadline was Nov 18, 2025, 4:00 PM EST).
Page kept for research and related open opportunities below. For current work in this category, use the related notices or browse hubs.
- Response deadline
- Nov 18, 2025, 4:00 PM EST
- Posted
- Nov 17, 2025
- Solicitation
- 12263311
- Set-aside
- No Set aside used
- Place of performance
- Camp Lejeune, NC, USA
- Contracting office
- DEFENSE HEALTH AGENCY · FREDERICK · MD
- Source
- SAM.gov · updated Jul 5, 2026
Description
The Defense Health Agency Contracting Activity (DHACA) Healthcare Contracting Division- Southeast (HCD-Southeast) intends to negotiate on a sole source basis IAW FAR 13.501(a), Only One Responsible Source. The proposed source is Fenwal, Inc., a Fresenius Kabi Company (Fenwal) of Three Corporate Drive, Lake Zurich, IL 60047. The Naval Medical Center Camp Lejeune (NMCCL), NC Blood Donor Center has a requirement for CPDA triple blood bags and Glycerolyte 57% Solution. The requested items shall be configured and validated for use with the Haemonetic ACP 215s that NMCCL currently owns. The items shall be Food and Drug Administration (FDA), which is approved for patient care. The requested supplies shall be configured and validated for use with the AMICUS� Separator Collection System that NMCCL currently owns. The supplies shall be delivered timely, and products shall be free of defects in accordance with federal and industry standards per Food and Drug Administration (FDA) regulations. The supplies shall be provided for a delivery period from 01 December 2025 � 30 September 2026. There are no set-aside restrictions for this requirement. The intended procurement will be classified under North America Industry Classification System (NAICS) 339112. This notice of intent is not a request for competitive proposals and no solicitation document exists for this requirement. However, parties interested in responding to this notice will need to submit technical data sufficient to determine capability in providing the same product. All capability statements received by the closing date of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. If a vendor challenges the basis of this requirement, please email product capability statements (formats for submission: PDF, MS Word, or MS Excel) to Gerrie Johnson at Gerrie.m.johnson.civ@health.mil . Closing date for challenges is no later than 4:00 PM ET on 18 November 2025. No phone calls will be accepted.
What similar awards have paid
Real federal awards already on the books in a similar lane — so you can size the opportunity, not guess. This is public history, not a bid price, cost estimate, or prediction that you will win.
Typical award size
$41,362
Middle of the pack for similar past awards
Most similar awards fall between $24,437 and $78,870
Who has won work like this
Public awardees in this lane — useful for competitor scan or teaming ideas, not a ranked list of “best” firms.
- 1IHEALTH INNOVATIVE SOLUTION LLC1 award$1.33M
- 2EUROIMMUN US INCORPORATED3 awards$200,991
- 3HARDY DIAGNOSTICS1 award$51,418
- 4LUMINEX CORP1 award$31,305
- 5NATIONAL ENVIRONMENTAL INC1 award$24,662
- 6BECTON, DICKINSON AND CO1 award$16,130
Drawn from official USAspending contract records in our index. Always confirm requirements on the SAM.gov notice before you bid.
Intelligence only — not legal advice or a guarantee of award. Always verify requirements on the official SAM.gov notice. Past award amounts are public history, not a suggested bid or prediction. Notice ID d93ae4656c0e4ccb9e3df8c9a6c73ac9.